Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders

Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Pendyala, Gurudutt, Fox, Howard S
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873800/
https://www.ncbi.nlm.nih.gov/pubmed/20353544
http://dx.doi.org/10.1186/gm143
_version_ 1782181396748435456
author Pendyala, Gurudutt
Fox, Howard S
author_facet Pendyala, Gurudutt
Fox, Howard S
author_sort Pendyala, Gurudutt
collection PubMed
description Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using proteomics include complement C3, soluble superoxide dismutase and a prostaglandin synthase. Metabolomics has not yet been widely used for biomarker discovery, but early work shows that it has great potential.
format Text
id pubmed-2873800
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28738002011-03-30 Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders Pendyala, Gurudutt Fox, Howard S Genome Med Review Diagnosing neurodegenerative diseases, monitoring their progression and assessing responses to treatments will all be aided by the identification of molecular markers of different stages of pathology. Protein biomarkers for HIV-associated neurocognitive disorders that have been discovered using proteomics include complement C3, soluble superoxide dismutase and a prostaglandin synthase. Metabolomics has not yet been widely used for biomarker discovery, but early work shows that it has great potential. BioMed Central 2010-03-30 /pmc/articles/PMC2873800/ /pubmed/20353544 http://dx.doi.org/10.1186/gm143 Text en Copyright ©2010 BioMed Central Ltd
spellingShingle Review
Pendyala, Gurudutt
Fox, Howard S
Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title_full Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title_fullStr Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title_full_unstemmed Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title_short Proteomic and metabolomic strategies to investigate HIV-associated neurocognitive disorders
title_sort proteomic and metabolomic strategies to investigate hiv-associated neurocognitive disorders
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873800/
https://www.ncbi.nlm.nih.gov/pubmed/20353544
http://dx.doi.org/10.1186/gm143
work_keys_str_mv AT pendyalagurudutt proteomicandmetabolomicstrategiestoinvestigatehivassociatedneurocognitivedisorders
AT foxhowards proteomicandmetabolomicstrategiestoinvestigatehivassociatedneurocognitivedisorders

Ejemplares similares